Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Reprod Domest Anim ; 47 Suppl 6: 278-80, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23279518

ABSTRACT

Two commercially available egg yolk-based semen extenders, one marketed for human semen freezing (HEYE) and one marketed for canine semen freezing (CEYE), were used to cryopreserve semen from single ejaculates of 11 different dogs. For each extender, a 30- and a 60-min cooldown period was used prior to the addition of the extender containing glycerol and then immediately frozen in liquid nitrogen vapours. Sperm motility was measured using a computer-assisted semen analysis (CASA) system. Sperm intact membranes were measured using SYBER-14 and propidium iodide. Semen in the HEYE cooled for 60 min had a significantly greater percentage of intact membranes than the semen in the HEYE cooled for 30 min (p = 0.02). Semen in the HEYE cooled for 60 min had significantly greater total motility (p = 0.007) and progressive motility (p = 0.004) than semen cooled for 60 min in the CEYE and semen cooled for 30 min in the HEYE (total motility p = 0.02 and progressive motility p = 0.02). Semen cooled for 60 min in the CEYE did not differ significantly in total (p = 0.6) or progressive motility (p = 0.4) than semen cooled for 30 min in the CEYE. There was no difference in total (p = 0.8) or progressive motility (p = 0.8) between the semen cooled for 30 min in the HEYE and the semen cooled for 30 min in the CEYE.


Subject(s)
Cell Membrane/physiology , Cold Temperature , Cryopreservation/veterinary , Egg Yolk , Spermatozoa/cytology , Spermatozoa/physiology , Animals , Dogs , Freezing , Male , Semen Analysis/veterinary , Semen Preservation/methods , Semen Preservation/veterinary , Sperm Motility , Time Factors
2.
Transfus Clin Biol ; 16(2): 179-89, 2009 May.
Article in French | MEDLINE | ID: mdl-19443252

ABSTRACT

The techniques for inactivation of pathogens in labile blood products (LBP) would appear to be the new strategy which will permit us to increase transfusion safety in the face of the risks of transmission of pathogenic agents by LBP. Various methods are in the course of development or already validated and used in France. The latter only apply however to plasma or platelet concentrates. The mechanisms of action and the efficacy of inactivation and attenuation of pathogenic agents vary with the different techniques. Each of these constitutes a preparative procedure composed of unit steps which have to be fully mastered in order to ensure the quality and transfusion efficacy of the treated product.


Subject(s)
Blood Banking/methods , Blood Preservation/methods , Blood-Borne Pathogens , Virus Inactivation , Blood Platelets/microbiology , Blood Transfusion , Hot Temperature , Humans , Methylene Blue/pharmacology , Photochemical Processes , Plasma , Quality Control , Safety , Ultraviolet Rays
3.
Transfus Clin Biol ; 16(2): 175-8, 2009 May.
Article in French | MEDLINE | ID: mdl-19446485

ABSTRACT

The preparation of labile blood products in a blood bank is in permanent technological progress. Many operations, such as blood centrifugation, components separation, etc. are now performed by automated devices. A new generation of equipments is able to prepare blood products by reducing the number of manual operations. Therefore, buffy-coat platelet concentrate preparation and whole blood preparation can be prepared by these automated systems. Consequently, this directly impacts working conditions of employees, quality of blood products and process management.


Subject(s)
Blood Banking/methods , Blood Preservation/methods , Automation , Blood Banks/standards , Blood Platelets/cytology , Cell Separation/methods , Humans , Quality Control
4.
Anesth Analg ; 85(6): 1233-9, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9390586

ABSTRACT

UNLABELLED: To assess the role of postoperative analgesia on myocardial ischemia after aortic surgery, we compared intravenous patient-controlled analgesia (PCA) with thoracic epidural analgesia (TEA). One hundred twenty-four patients were prospectively randomized to the PCA or TEA group. In the TEA group, a T6-7 or T7-8 epidural catheter was inserted before the induction of general anesthesia. Within 1 h of the end of surgery, analgesia and 24-h two-channel Holter monitoring were begun. Myocardial ischemia was defined as ST segment depression > or = 1 mm, 0.06 s after the J point, and lasting for more than 1 min. In the PCA group, a bolus of morphine, 0.05 mg/kg, was given, followed by 0.02 mg/kg of morphine on demand every 10 min. Bupivacaine 0.125% and fentanyl 10 microg/mL was used in the TEA group. Analgesics were titrated to maintain a visual analog scale score < or = 3. The overall incidence of myocardial ischemia was 18.4%-18.2% for TEA and 18.6% for PCA (P = not significant). There were no differences between the groups in the total duration of ischemia per patient (22.2 +/- 119.8 min for TEA and 20.5 +/- 99 min for PCA) and the number of episodes per patient (0.69 +/- 2.1 for TEA and 1.2 +/- 4.9 for PCA). Twenty-three patients had an adverse cardiac outcome, although there were no differences between the groups. The postoperative pain control was superior with TEA. In these patients undergoing elective aortic surgery, the use of postoperative TEA did not result in a lower incidence of early myocardial ischemia compared with intravenous PCA with morphine, despite better analgesia with TEA. IMPLICATIONS: Postoperative myocardial ischemia is associated with adverse cardiac outcome. Using Holter monitoring after aortic surgery, this study shows that the use of thoracic epidural analgesia with bupivacaine and fentanyl did not result in a lower incidence of myocardial ischemia compared with intravenous patient-controlled analgesia with morphine.


Subject(s)
Analgesia, Epidural , Analgesia, Patient-Controlled , Aorta, Abdominal/surgery , Myocardial Ischemia/etiology , Postoperative Complications , Aged , Analgesics, Opioid/administration & dosage , Anesthetics, Local/administration & dosage , Bupivacaine/administration & dosage , Electrocardiography, Ambulatory , Female , Fentanyl/administration & dosage , Humans , Male , Morphine/administration & dosage , Myocardial Ischemia/diagnosis , Pain Measurement , Pain, Postoperative/drug therapy , Prospective Studies
5.
J Pharm Pharmacol ; 47(3): 193-6, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7602479

ABSTRACT

Minimum inhibitory concentrations (MICs) of seven independent isolates of Staphylococcus hominis isolated in the same week from used eye-drops, preserved with thiomersal and collected from wards and clinics in the same hospital, ranged between 1 and 0.03 mg L-1 for thiomersal, 1 and 0.01 mg L-1 for phenyl mercuric nitrate and 10 and 3 mg L-1 for mercuric chloride. Although MIC values determined on solid nutrient medium indicated a 100-fold variation in susceptibility to the bacteriostatic effect of phenyl mercuric nitrate, after 5 h in an aqueous solution containing the bactericidal concentration of 10 mg L-1 phenyl mercuric nitrate, the survival levels of the six S. hominis isolates were similar, with a mean of 13.4% (s.d. 11.0), compared with 100 and 0.8%, respectively, for the most resistant and most sensitive control staphylococcal strains tested. Antibiotic susceptibilities and plasmid profiles of the S. hominis isolates indicated they were the same strain. It is concluded that laboratory indicators of preservative efficacy, such as MIC determination or susceptibility to bactericidal concentrations of preservatives, do not necessarily correlate with the epidemiology of contaminating bacterial strains or their survival in preserved pharmaceuticals.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Mercuric Chloride/pharmacology , Phenylmercury Compounds/pharmacology , Preservatives, Pharmaceutical/pharmacology , Staphylococcus/drug effects , Thimerosal/pharmacology , Anti-Infective Agents, Local/analysis , Dexamethasone/chemistry , Dexamethasone/standards , Drug Resistance, Microbial , Drug Storage , Electrophoresis, Polyacrylamide Gel , Humans , Mercuric Chloride/analysis , Microbial Sensitivity Tests , Ophthalmic Solutions/standards , Phenylmercury Compounds/analysis , Plasmids/isolation & purification , Preservatives, Pharmaceutical/analysis , Thimerosal/analysis
6.
J Antimicrob Chemother ; 35(1): 7-22, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7768784

ABSTRACT

The later-generation cephalosporins were developed to overcome beta-lactamases which conferred resistance to earlier beta-lactam drugs. Within two years of their clinical introduction, the ubiquitous TEM and SHV plasmid-encoded beta-lactamase genes underwent simple point mutations that changed key amino acids around the active site of the protein and enabled the enzyme to bind and hydrolyse these new drugs. Successive mutations interacted in concert, radically increasing the enzymes' abilities to bind and confer resistance to later-generation cephalosporins. These modified enzymes have been classified in three groups, based on activity, and altered functions have been correlated with changes in the enzyme structure.


Subject(s)
Bacteria/enzymology , beta-Lactamases/metabolism , Amino Acid Sequence , Bacteria/drug effects , Bacteria/genetics , Bacterial Infections/microbiology , Humans , Molecular Sequence Data , beta-Lactamases/chemistry
7.
J Hosp Infect ; 20(2): 97-103, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1348768

ABSTRACT

During an 8-month period, Klebsiella pneumoniae resistant to cefotaxime and ceftazidime were isolated from 18 elderly patients in two closely-situated UK hospitals. Amongst these 18 patients, the organisms were isolated from urine samples of 17, from blood cultures of two and from a wound swab of one. The infected patients were located in nine different wards and several of the patients had been transferred between wards, within and between the two hospitals. All the bacterial isolates belonged to serotype K62, were non-typable or reacted only weakly with bacteriophage, showed similar plasmid profiles and were resistant to tetracycline and trimethoprim, thus indicating they were the same strain. Resistance to cefotaxime and ceftazidime was inhibited by clavulanic acid suggesting the involvement of extended-spectrum beta-lactamase (ESBL) enzyme activity. This was confirmed by analytical isoelectric focusing, which showed that isolates each produced two beta-lactamases with isoelectric points of 7.0(SHV-3) and 7.6 (SHV-1/2) respectively.


Subject(s)
Cross Infection/epidemiology , Disease Outbreaks , Klebsiella Infections/epidemiology , Klebsiella pneumoniae , Cefotaxime/pharmacology , Ceftazidime/pharmacology , Drug Resistance, Microbial , Humans , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests , Species Specificity , United Kingdom/epidemiology , beta-Lactamases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...